Modifiable risk factors versus age on developing high predicted cardiovascular disease risk in blacks

Adam P. Bress, Lisandro D. Colantonio, John N. Booth, Tanya M. Spruill, Joseph Ravenell, Mark Butler, Amanda J. Shallcross, Samantha R. Seals, Kristi Reynolds, Gbenga Ogedegbe, Daichi Shimbo, Paul Muntner

Research output: Contribution to journalArticle

Abstract

Background-Clinical guidelines recommend using predicted atherosclerotic cardiovascular disease (ASCVD) risk to inform treatment decisions. The objective was to compare the contribution of changes in modifiable risk factors versus aging to the development of high 10-year predicted ASCVD risk. Methods and Results-A prospective follow-up was done of the Jackson Heart Study, an exclusively black cohort at visit 1 (2000-2004) and visit 3 (2009-2012). Analyses included 1115 black participants without high 10-year predicted ASCVD risk (<7.5%), hypertension, diabetes mellitus, or ASCVD at visit 1. We used the Pooled Cohort equations to calculate the incidence of high (≥7.5%) 10-year predicted ASCVD risk at visit 3. We recalculated the percentage with high 10-year predicted ASCVD risk at visit 3 assuming each risk factor (age, systolic blood pressure, antihypertensive medication use, diabetes mellitus, smoking, total and high-density lipoprotein cholesterol), one at a time, did not change from visit 1. The mean age at visit 1 was 45.2±9.5 years. Overall, 30.9% (95% CI 28.3-33.4%) of participants developed high 10-year predicted ASCVD risk. Aging accounted for 59.7% (95% CI 54.2-65.1%) of the development of high 10-year predicted ASCVD risk compared with 32.8% (95% CI 27.0-38.2%) for increases in systolic blood pressure or antihypertensive medication initiation and 12.8% (95% CI 9.6-16.5%) for incident diabetes mellitus. Among participants <50 years, the contribution of increases in systolic blood pressure or antihypertensive medication initiation was similar to aging. Conclusions-Increases in systolic blood pressure and antihypertensive medication initiation are major contributors to the development of high 10-year predicted ASCVD risk in blacks, particularly among younger adults.

Original languageEnglish (US)
Article numbere005054
JournalJournal of the American Heart Association
Volume6
Issue number2
DOIs
StatePublished - 2017

Fingerprint

Cardiovascular Diseases
Blood Pressure
Antihypertensive Agents
Diabetes Mellitus
HDL Cholesterol
Young Adult
Smoking
Guidelines
Hypertension
Incidence

Keywords

  • Atherosclerotic cardiovascular disease risk
  • Blacks
  • Blood pressure
  • Hypertension
  • Population

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Bress, A. P., Colantonio, L. D., Booth, J. N., Spruill, T. M., Ravenell, J., Butler, M., ... Muntner, P. (2017). Modifiable risk factors versus age on developing high predicted cardiovascular disease risk in blacks. Journal of the American Heart Association, 6(2), [e005054]. https://doi.org/10.1161/JAHA.116.005054

Modifiable risk factors versus age on developing high predicted cardiovascular disease risk in blacks. / Bress, Adam P.; Colantonio, Lisandro D.; Booth, John N.; Spruill, Tanya M.; Ravenell, Joseph; Butler, Mark; Shallcross, Amanda J.; Seals, Samantha R.; Reynolds, Kristi; Ogedegbe, Gbenga; Shimbo, Daichi; Muntner, Paul.

In: Journal of the American Heart Association, Vol. 6, No. 2, e005054, 2017.

Research output: Contribution to journalArticle

Bress, AP, Colantonio, LD, Booth, JN, Spruill, TM, Ravenell, J, Butler, M, Shallcross, AJ, Seals, SR, Reynolds, K, Ogedegbe, G, Shimbo, D & Muntner, P 2017, 'Modifiable risk factors versus age on developing high predicted cardiovascular disease risk in blacks', Journal of the American Heart Association, vol. 6, no. 2, e005054. https://doi.org/10.1161/JAHA.116.005054
Bress, Adam P. ; Colantonio, Lisandro D. ; Booth, John N. ; Spruill, Tanya M. ; Ravenell, Joseph ; Butler, Mark ; Shallcross, Amanda J. ; Seals, Samantha R. ; Reynolds, Kristi ; Ogedegbe, Gbenga ; Shimbo, Daichi ; Muntner, Paul. / Modifiable risk factors versus age on developing high predicted cardiovascular disease risk in blacks. In: Journal of the American Heart Association. 2017 ; Vol. 6, No. 2.
@article{ebb833a091974272b95c4035d4fd8827,
title = "Modifiable risk factors versus age on developing high predicted cardiovascular disease risk in blacks",
abstract = "Background-Clinical guidelines recommend using predicted atherosclerotic cardiovascular disease (ASCVD) risk to inform treatment decisions. The objective was to compare the contribution of changes in modifiable risk factors versus aging to the development of high 10-year predicted ASCVD risk. Methods and Results-A prospective follow-up was done of the Jackson Heart Study, an exclusively black cohort at visit 1 (2000-2004) and visit 3 (2009-2012). Analyses included 1115 black participants without high 10-year predicted ASCVD risk (<7.5{\%}), hypertension, diabetes mellitus, or ASCVD at visit 1. We used the Pooled Cohort equations to calculate the incidence of high (≥7.5{\%}) 10-year predicted ASCVD risk at visit 3. We recalculated the percentage with high 10-year predicted ASCVD risk at visit 3 assuming each risk factor (age, systolic blood pressure, antihypertensive medication use, diabetes mellitus, smoking, total and high-density lipoprotein cholesterol), one at a time, did not change from visit 1. The mean age at visit 1 was 45.2±9.5 years. Overall, 30.9{\%} (95{\%} CI 28.3-33.4{\%}) of participants developed high 10-year predicted ASCVD risk. Aging accounted for 59.7{\%} (95{\%} CI 54.2-65.1{\%}) of the development of high 10-year predicted ASCVD risk compared with 32.8{\%} (95{\%} CI 27.0-38.2{\%}) for increases in systolic blood pressure or antihypertensive medication initiation and 12.8{\%} (95{\%} CI 9.6-16.5{\%}) for incident diabetes mellitus. Among participants <50 years, the contribution of increases in systolic blood pressure or antihypertensive medication initiation was similar to aging. Conclusions-Increases in systolic blood pressure and antihypertensive medication initiation are major contributors to the development of high 10-year predicted ASCVD risk in blacks, particularly among younger adults.",
keywords = "Atherosclerotic cardiovascular disease risk, Blacks, Blood pressure, Hypertension, Population",
author = "Bress, {Adam P.} and Colantonio, {Lisandro D.} and Booth, {John N.} and Spruill, {Tanya M.} and Joseph Ravenell and Mark Butler and Shallcross, {Amanda J.} and Seals, {Samantha R.} and Kristi Reynolds and Gbenga Ogedegbe and Daichi Shimbo and Paul Muntner",
year = "2017",
doi = "10.1161/JAHA.116.005054",
language = "English (US)",
volume = "6",
journal = "Journal of the American Heart Association",
issn = "2047-9980",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Modifiable risk factors versus age on developing high predicted cardiovascular disease risk in blacks

AU - Bress, Adam P.

AU - Colantonio, Lisandro D.

AU - Booth, John N.

AU - Spruill, Tanya M.

AU - Ravenell, Joseph

AU - Butler, Mark

AU - Shallcross, Amanda J.

AU - Seals, Samantha R.

AU - Reynolds, Kristi

AU - Ogedegbe, Gbenga

AU - Shimbo, Daichi

AU - Muntner, Paul

PY - 2017

Y1 - 2017

N2 - Background-Clinical guidelines recommend using predicted atherosclerotic cardiovascular disease (ASCVD) risk to inform treatment decisions. The objective was to compare the contribution of changes in modifiable risk factors versus aging to the development of high 10-year predicted ASCVD risk. Methods and Results-A prospective follow-up was done of the Jackson Heart Study, an exclusively black cohort at visit 1 (2000-2004) and visit 3 (2009-2012). Analyses included 1115 black participants without high 10-year predicted ASCVD risk (<7.5%), hypertension, diabetes mellitus, or ASCVD at visit 1. We used the Pooled Cohort equations to calculate the incidence of high (≥7.5%) 10-year predicted ASCVD risk at visit 3. We recalculated the percentage with high 10-year predicted ASCVD risk at visit 3 assuming each risk factor (age, systolic blood pressure, antihypertensive medication use, diabetes mellitus, smoking, total and high-density lipoprotein cholesterol), one at a time, did not change from visit 1. The mean age at visit 1 was 45.2±9.5 years. Overall, 30.9% (95% CI 28.3-33.4%) of participants developed high 10-year predicted ASCVD risk. Aging accounted for 59.7% (95% CI 54.2-65.1%) of the development of high 10-year predicted ASCVD risk compared with 32.8% (95% CI 27.0-38.2%) for increases in systolic blood pressure or antihypertensive medication initiation and 12.8% (95% CI 9.6-16.5%) for incident diabetes mellitus. Among participants <50 years, the contribution of increases in systolic blood pressure or antihypertensive medication initiation was similar to aging. Conclusions-Increases in systolic blood pressure and antihypertensive medication initiation are major contributors to the development of high 10-year predicted ASCVD risk in blacks, particularly among younger adults.

AB - Background-Clinical guidelines recommend using predicted atherosclerotic cardiovascular disease (ASCVD) risk to inform treatment decisions. The objective was to compare the contribution of changes in modifiable risk factors versus aging to the development of high 10-year predicted ASCVD risk. Methods and Results-A prospective follow-up was done of the Jackson Heart Study, an exclusively black cohort at visit 1 (2000-2004) and visit 3 (2009-2012). Analyses included 1115 black participants without high 10-year predicted ASCVD risk (<7.5%), hypertension, diabetes mellitus, or ASCVD at visit 1. We used the Pooled Cohort equations to calculate the incidence of high (≥7.5%) 10-year predicted ASCVD risk at visit 3. We recalculated the percentage with high 10-year predicted ASCVD risk at visit 3 assuming each risk factor (age, systolic blood pressure, antihypertensive medication use, diabetes mellitus, smoking, total and high-density lipoprotein cholesterol), one at a time, did not change from visit 1. The mean age at visit 1 was 45.2±9.5 years. Overall, 30.9% (95% CI 28.3-33.4%) of participants developed high 10-year predicted ASCVD risk. Aging accounted for 59.7% (95% CI 54.2-65.1%) of the development of high 10-year predicted ASCVD risk compared with 32.8% (95% CI 27.0-38.2%) for increases in systolic blood pressure or antihypertensive medication initiation and 12.8% (95% CI 9.6-16.5%) for incident diabetes mellitus. Among participants <50 years, the contribution of increases in systolic blood pressure or antihypertensive medication initiation was similar to aging. Conclusions-Increases in systolic blood pressure and antihypertensive medication initiation are major contributors to the development of high 10-year predicted ASCVD risk in blacks, particularly among younger adults.

KW - Atherosclerotic cardiovascular disease risk

KW - Blacks

KW - Blood pressure

KW - Hypertension

KW - Population

UR - http://www.scopus.com/inward/record.url?scp=85015979581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015979581&partnerID=8YFLogxK

U2 - 10.1161/JAHA.116.005054

DO - 10.1161/JAHA.116.005054

M3 - Article

C2 - 28179220

AN - SCOPUS:85015979581

VL - 6

JO - Journal of the American Heart Association

JF - Journal of the American Heart Association

SN - 2047-9980

IS - 2

M1 - e005054

ER -